Heather Katz, DO, FACOI, FACP, is a board-certified hematologist and medical oncologist specializing in the diagnosis and treatment of solid tumors and hematologic malignancies. Her clinical expertise includes cancers of the breast, gastrointestinal tract, head and neck, genitourinary system, lung, and gynecologic organs, as well as hematologic conditions such as leukemia, lymphoma, and multiple myeloma. Dr. Katz is committed to delivering comprehensive, evidence-based care grounded in compassion and respect for each patient’s individual journey. She emphasizes shared decision-making, continuity of care, and clear communication to empower patients and their families throughout treatment and survivorship. Dr. Katz earned her Bachelor of Science in Biology, with a minor in Human Development, from the State University of New York at Geneseo. She received her medical degree from Rocky Vista University College of Osteopathic Medicine in Parker, Colorado, and completed her internal medicine residency at Broward Health Medical Center in Fort Lauderdale, Florida, where she served as Chief Resident and was named Resident of the Year. She went on to complete her fellowship in Hematology and Medical Oncology at Marshall University’s Joan C. Edwards School of Medicine in Huntington, West Virginia, serving as Chief Fellow in her final year. Board certified in Internal Medicine, Medical Oncology, and Hematology by the American Osteopathic Board of Internal Medicine, Dr. Katz is a Fellow of both the American College of Osteopathic Internists and the American College of Physicians. She has presented at numerousnational oncology conferences and is the author of over 15 peer-reviewed publications in the medical literature. Dr. Katz is dedicated not only to clinical excellence but also to advancing the field of oncology through research, education, and mentorship. Her patients recognize her for her thoughtful bedside manner, personalized treatment planning, and unwavering commitment to high-quality care. . Dr. Katz is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Salpingo-Oophorectomy.

Joana S. Emmolo, MD is a board certified radiation oncologist at Atlantic Health System's Overlook Medical Center and CyberKnife Center. She is a member of various tumor boards for the Carol G. Simon Cancer Center and The Gerald J. Glasser Brain Tumor Center. Dr. Emmolo has a focus on brain tumors and breast cancer, with a special interest in accelerated and minimally invasive treatment options for both disease sites. She attended the University of Medicine and Dentistry of New Jersey in Newark, NJ and served as Chief Resident at New York Methodist Hospital in Brooklyn, NY. Dr. Emmolo speaks Spanish and Italian. In her free time, Dr. Emmolo enjoys spending time with her two young boys and travelling with family. Dr. Emmolo is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Radiation Induced Meningioma, Posterior Fossa Tumor, Meningioma, and Pleuropulmonary Blastoma.

Joseph P. Weiner is a board-certified and fellowship-trained radiation oncologist at Atlantic Health System's Overlook Medical Center and CyberKnife Center. He is a member of various tumor boards for the Carol G. Simon Cancer Center. He is also the co-founder of the Prostate Cancer Multidisciplinary and Second Opinion Clinic at Overlook Medical Center. Dr. Weiner is an active member of the Gerald J. Glasser Brain Tumor Center as well.Dr. Weiner is trained to treat all oncologic conditions but has advanced fellowship training and a special interest in both prostate and brain tumors. He has published over 40 peer-reviewed articles on these topics, written numerous book chapters as well as given regional and national lectures at prominent oncologic conferences. Dr. Weiner was previously involved in the training of over 15 resident physicians to become attending Radiation Oncologists, as well as mentored numerous medical students seeking experience in oncology.Dr. Weiner has professional experience with multiple radiation delivery platforms, including fellowship training with the team that invented the CyberKnife Radiosurgery unit. He also has experience with gantry-based linear accelerators such as the Varian TrueBeam. He has previously worked with Proton Beam Therapy, both high-dose rate (HDR) and low-dose rate (LDR) Brachytherapy, and the Gamma Knife Radiosurgery unit. He is able to perform three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), and stereotactic body radiotherapy (SBRT). Dr. Weiner is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Radiation Induced Meningioma, Oligodendroglioma, and Prostatectomy.

Dr. Yaron Moshel is recognized not only for his distinguished expertise but also for his warmth and patience, making him one of the most skilled and forward-thinking neurosurgeons in the field. His patient-centered approach—coupled with a commitment to pioneering new treatments and technologies—continues to revolutionize comprehensive brain tumor care, providing hope when it’s needed most.One of a select few neurosurgeons specializing in the removal of deep-seated benign and malignant brain and skull base tumors, Dr. Moshel integrates advanced techniques such as computer-guided navigation, awake surgery, intraoperative brain mapping, endoscopy, and microsurgery to achieve optimal outcomes. His expertise also includes 5-ALA fluorescent imaging and both open and minimally invasive skull base approaches, further enhancing precision and safety in complex neurosurgical procedures.A leader in innovation, he is at the forefront of Laser Interstitial Thermal Therapy (LITT), Fluorescent Brain Tumor Surgery, Brachytherapy, and Intracavitary Chemotherapy, expanding the possibilities for complex tumor treatment.Dr. Moshel plays a pivotal role in Atlantic Health’s CyberKnife® TrueBeam® program, contributing to the largest Stereotactic Radiosurgery Program in the tri-state region for brain tumor treatment. Actively engaged in research, he also participates in national multicenter clinical trials, driving advancements in the field. Dr. Moshel is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Meningioma, Glioma, Glioblastoma, Awake Craniotomy, and Gamma Knife Radiosurgery.

Rajesh Iyer is a Radiation Oncologist in Livingston, New Jersey. Dr. Iyer is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Familial Pancreatic Cancer.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Andy Rodriguez is a Neurologist in Livingston, New Jersey. Dr. Rodriguez has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Seizures, Memory Loss, Landau-Kleffner Syndrome, Autosomal Dominant Partial Epilepsy with Auditory Features, and Gastrostomy. Dr. Rodriguez is currently accepting new patients.

Eric Geller is a Neurologist in Livingston, New Jersey. Dr. Geller is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Seizures, Partial Familial Epilepsy, Epilepsy, Deep Brain Stimulation, and Gastrostomy. Dr. Geller is currently accepting new patients.

Karleung Siu is a Hematologist and an Oncologist in Florham Park, New Jersey. Dr. Siu is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Siu is currently accepting new patients.

Said Saleh is a Hematologist in West Orange, New Jersey. Dr. Saleh is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Iron Deficiency Anemia, Thrombocytopenia, Childhood Iron Deficiency Anemia, Anemia, and Endoscopy.

James Orsini is a Hematologist in West Orange, New Jersey. Dr. Orsini is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Colorectal Cancer, Iron Deficiency Anemia, Familial Prostate Cancer, Lung Cancer, and Bone Marrow Aspiration.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Posterior Fossa Tumor.

Dr. Robert Aiken is a fellowship-trained neuro-oncologist and part of the Atlantic Medical Group Neuroscience Institute at Overlook Medical Center. With years of expertise in academic, clinical and administrative roles, and board-certified in neurology and neuro-oncology, he specializes in the diagnosis and management of patients with brain tumors, tumors of the spinal cord and nerves, as well as the management of paraneoplastic disorders involving the brain and nervous system. His particular interest involves translating new discoveries and developing new therapies for these disorders. A devoted researcher and educator, Dr. Aiken serves as co-director of the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He also served as director of neuro-oncology at Rutgers-Cancer Institute of New Jersey of Rutgers University. Previously, he held academic appointments in neurology, neurosurgery and oncology at Mount Sinai School of Medicine in NYC and Rush University Medical Center in Chicago. He combines clinical knowledge and extensive research in brain and spinal tumors. Dr. Aiken provides patients with a comprehensive evaluation and discusses their disease at length and the available treatments. After receiving his medical degree from Wayne State University School of Medicine in Detroit, MI, Dr. Aiken completed an internship and residency in internal medicine at Baylor College of Medicine in Houston, TX, then pursued neurologic training at the Neurological Institute of New York, Columbia-Presbyterian Medical Center. Post-residency, Dr. Aiken received his fellowship training at Memorial Sloan-Kettering Cancer Center. He is the author of many professional research journal articles. Dr. Aiken has been named among America’s Top Doctors and America’s Top Doctors for Cancer from Castle Connolly, Best Doctors in Philadelphia, New York and Chicago and by Inside Jersey magazine. He is on many best doctors lists. Dr. Aiken is part of Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization. Dr. Aiken is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliosarcoma.

Dr. Nicholas Metrus is a board-certified, fellowship-trained neurologist/neuro-oncologist with Atlantic Medical Group Neuroscience Associates and the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He is a specialist in the diagnosis and treatment of patients with brain tumors and conditions of the central nervous system. Dr. Metrus is part of a medical team that works together to provide exceptional personalized care for every patient using a multidisciplinary and comprehensive approach. His commitment to individualized care includes designing and overseeing each patient’s treatment plan, which can include any combination of chemotherapy, target therapy, and immunotherapy.Throughout his medical education, Dr. Metrus devoted his time to cutting-edge research and publishing his work on topics such as paraneoplastic disorders, tumefactive multiple sclerosis, and clinical trial enrollment, to name a few. He has also published book chapters on ependymomas and advances in clinical trial design for brain tumors. He pursed his fellowship training in neuro-oncology at MD Anderson Cancer Center, where he was the 2018 recipient of a research grant, the William James Miller Endowed Fellowship Award, for his work in Guillain Barre Syndrome following stem cell transplants, and again in 2019 for his description of unique presentations of cancer in the brain.His research on hypermutator gliomas has been presented at national and international medical conferences. Dr. Metrus earned his medical degree from the American University of the Caribbean and went on to complete his residency in neurology at the University of Texas Medical Branch. Dr. Metrus is a participating provider of the Atlantic Accountable Care Organization. Dr. Metrus is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Meningioma, Glioma, Oligodendroglioma, and Astrocytoma.

Dr. Frisoli is a highly skilled neurosurgeon whose expertise in brain tumor and skull base surgery makes him an invaluable asset to the Gerald J. Glasser Brain Tumor Center. With extensive fellowship training, he brings a wealth of specialized insight to the treatment of complex brain and skull base tumors, ensuring patients receive the most advanced, personalized care.Beyond his surgical precision, Dr. Frisoli is known for his unparalleled compassion, providing every patient with thoughtful, individualized care. His forward-thinking, meticulous approach allows him to deliver the safest, most effective treatments for even the most challenging brain and spine conditions.A leader in innovation, Dr. Frisoli is actively advancing the fields of minimally invasive spine surgery and state-of-the-art artificial disc replacement technology, continually pushing the boundaries of neurosurgical excellence. Dr. Frisoli is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Pica, Posterior Fossa Tumor, Dysembryoplastic Neuroepithelial Tumors (DNET), Awake Craniotomy, and Thrombectomy.

Dr. Brian Beyerl graduated Summa Cum Laude and was elected to Phi Beta Kappa while earning his Bachelor of Science degree from the University of Wisconsin–Madison. He went on to receive his medical degree from Johns Hopkins School of Medicine in Baltimore, Maryland. His post-graduate training included general surgery at Johns Hopkins Hospital and a neurosurgical residency at Massachusetts General Hospital, Harvard Medical School in Boston, Massachusetts. He became board-certified by the American Board of Neurological Surgery in 1990.Throughout his distinguished career as a brain tumor neurosurgeon, Dr. Beyerl co-directed the Atlantic Health Stereotactic Radiosurgery Program alongside Dr. Lou Schwartz. This pioneering program was the first in New Jersey to treat brain tumors with pinpoint radiation.Since retiring from active surgery in 2019, Dr. Beyerl has remained dedicated to patient care. As a Patient and Family Advocate at the Glasser Brain Tumor Center at Overlook Medical Center and Morristown Medical Center, he provides crucial support to brain tumor patients and their families. His role includes counseling, guidance on treatment transitions, and end-of-life care decisions, including hospice discussions.As a Permanent Deacon in the Catholic Church, Dr. Beyerl also offers spiritual support to those who seek it. He actively participates in monthly Brain Tumor Support and Caregiver Support Groups, ensuring that patients and families receive both medical guidance and emotional support throughout their journey. Dr. Beyerl is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Pallister-Hall Syndrome, Choroid Plexus Papilloma, Meningioma, and Radiation Induced Meningioma.

Nawal Shaikh is a Neurologist and a Neuromusculoskeletal Medicine provider in Livingston, New Jersey. Dr. Shaikh has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Neurofibromatosis, Brain Tumor, Astrocytoma, and Glioma.

David Huang is a Radiation Oncologist in Livingston, New Jersey. Dr. Huang is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Metastatic Brain Tumor, Radiation Induced Meningioma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

James Liu is a Neurosurgery provider in Livingston, New Jersey. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Glomus Tympanum Tumor, Glomus Jugulare Tumor, Pituitary Tumor, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.